Healthcare News and Research RSS Feed - Healthcare News and Research

New Cannabis and Cannabinoid Research journal to be launched in fall 2015

New Cannabis and Cannabinoid Research journal to be launched in fall 2015

Cannabis and Cannabinoid Research, a new peer-reviewed, open access journal from Mary Ann Liebert, Inc., publishers, is the only journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids. [More]
Sofosbuvir in combination with ribavirin/peginterferon achieves highest SVR rates in GT-3 HCV patients

Sofosbuvir in combination with ribavirin/peginterferon achieves highest SVR rates in GT-3 HCV patients

Results presented today at The International Liver Congress 2015 demonstrate that hepatitis C (HCV)-infected genotype-3 (GT-3) patients, with and without cirrhosis, receiving 24 weeks of sofosbuvir (SOF) in combination with ribavirin (RBV) and peginterferon (PEG) achieved the highest sustained virologic response rates at 12 weeks (SVR12), observed in a Phase 3 study, to date. [More]
Birmingham City University event to focus on digital future of NHS

Birmingham City University event to focus on digital future of NHS

The digital future of the NHS will be the focus of a free Birmingham City University event next week. 'Healthcare in a Digital Age' takes place on Thursday 30 April and will see innovators Edward Miller and Robin Vickers lead discussions on the digitisation of patient information and the integration of services giving patients more control over their healthcare. [More]
Combination treatment effective for HCV genotype-1 mono-infected patients

Combination treatment effective for HCV genotype-1 mono-infected patients

Results presented today at The International Liver Congress 2015 show that the sofosbuvir (SOF)/daclatasvir (DCV) treatment combination is effective amongst hepatitis C virus (HCV) genotype-1 mono-infected patients. These results are significant because whilst other combinations have been widely reported on, there have been few data until now regarding the use of SOF/DCV combination in real world situations. [More]
iCAD announces adoption of Xoft Axxent Electronic Brachytherapy System in Spain

iCAD announces adoption of Xoft Axxent Electronic Brachytherapy System in Spain

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced the first Xoft Axxent Electronic Brachytherapy (eBx) System in Spain is now available at the Hospital Miguel Servet for the treatment of early-stage breast cancer, non-melanoma skin cancer and gynecological cancers. [More]
NPC recognized as top ranking company on DiversityInc Top 50 Companies for Diversity list

NPC recognized as top ranking company on DiversityInc Top 50 Companies for Diversity list

Novartis Pharmaceuticals Corporation has been named the top company for diversity for the second year in a row on the annual DiversityInc Top 50 Companies for Diversity listing. DiversityInc announced the results of its 2015 Top 50 Companies for Diversity on April 23 at an awards ceremony in New York, NY. [More]
U-M study: Nearly half of American hospitals not taking key steps to prevent C. diff infections

U-M study: Nearly half of American hospitals not taking key steps to prevent C. diff infections

Nearly half of American hospitals aren't taking key steps to prevent a kind of gut infection that kills nearly 30,000 people annually and sickens hundreds of thousands more - despite strong evidence that such steps work, according to a new study. [More]
PCMH care model gaining acceptance in primary care, specialist practices

PCMH care model gaining acceptance in primary care, specialist practices

Primary-care physicians play a pivotal role in assuring that patients who require specialized care are transitioned properly from one clinical environment to another to help lower the risks for adverse events and repeat hospitalizations, according to a health quality management expert who spoke today at the National Quality Summit sponsored by the National Association for Healthcare Quality. [More]
Proviso Partners for Health awarded IHI grant to improve community health

Proviso Partners for Health awarded IHI grant to improve community health

The Proviso Partners for Health was awarded a grant from the Institute of Healthcare Improvement to support their efforts to improve community health. Proviso Partners for Health is comprised of Loyola University Health System, Loyola University Chicago Stritch School of Medicine and Marcella Niehoff School of Nursing as well as Proviso-Leyden Council for Community Action, Proviso East High School, Triton College, Cook County Department of Public Health and several other community organizations. [More]

Baylor Scott & White Health opens new service company headquarters in Temple, Texas

Baylor Scott & White Health today opened new offices for the headquarters of Baylor Scott & White Health Service Company in Temple. Located adjacent to the historic Scott & White Clinic, Baylor Scott & White Health Service Company's offices feature collaboration-friendly spaces that reflect the organization's emphasis on innovation in bringing health care services to patients across central and north Texas. [More]
Looking for standardized approach to testing twilight vision

Looking for standardized approach to testing twilight vision

A simple method of testing "twilight vision" gives reliable results in identifying people who have decreased visual acuity under low light conditions, according to a study in the May issue of Optometry and Vision Science, official journal of the American Academy of Optometry. [More]
Researchers identify potential treatment target for fragile X carriers

Researchers identify potential treatment target for fragile X carriers

Fragile X syndrome, an inherited cause of autism and intellectual disability, can have consequences even for carriers of the disorder who don't have full-blown symptoms. [More]
Actavis reports positive results from phase 3 study of single-dose DALVANCE for treatment of ABSSSI

Actavis reports positive results from phase 3 study of single-dose DALVANCE for treatment of ABSSSI

Actavis plc today announced positive top-line results for study DUR001-303, a phase 3 study comparing a single 1500 mg dose of DALVANCE with the same total dose given as two-doses one week apart, for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria, including methicillin resistant Staphylococcus aureus (MRSA). [More]
Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Natera, Inc., a global leader in non-invasive genetic testing, and LifeLabs Medical Laboratory Services today announced a new agreement that gives LifeLabs the rights to perform non-invasive prenatal testing (NIPT) in Canada using Natera technology. [More]
Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Eli Lilly and Company has received its fourth U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab). CYRAMZA (ramucirumab injection 10 mg/mL solution) is now also indicated in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil) chemotherapy for the treatment of patients with metastatic colorectal cancer (mCRC) with disease progression on or after prior therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine. [More]
Study: Long-term exposure to air pollution can damage brain structures, impair cognitive function

Study: Long-term exposure to air pollution can damage brain structures, impair cognitive function

Air pollution, even at moderate levels, has long been recognized as a factor in raising the risk of stroke. A new study led by scientists from Beth Israel Deaconess Medical Center and Boston University School of Medicine suggests that long-term exposure can cause damage to brain structures and impair cognitive function in middle-aged and older adults. [More]
New research shows how fat controls energy levels in the brain

New research shows how fat controls energy levels in the brain

An enzyme secreted by the body's fat tissue controls energy levels in the brain, according to new research at Washington University School of Medicine in St. Louis. The findings, in mice, underscore a role for the body's fat tissue in controlling the brain's response to food scarcity, and suggest there is an optimal amount of body fat for maximizing health and longevity. [More]
Fruit fly study shows that extra sleep helps the brain overcome neurological defects

Fruit fly study shows that extra sleep helps the brain overcome neurological defects

Many studies have linked more sleep to better memory, but new research in fruit flies demonstrates that extra sleep helps the brain overcome catastrophic neurological defects that otherwise would block memory formation, report scientists at Washington University School of Medicine in St. Louis. [More]
Vestagen Technical Textiles' VESTEX receives two notable innovation awards

Vestagen Technical Textiles' VESTEX receives two notable innovation awards

Vestagen Technical Textiles, Inc. today announced that its proprietary textile technology, VESTEX, has recently received two notable innovation awards. The first is the prestigious Edison Award, a global competition that recognizes innovations with potential to create a positive impact in the world. [More]
Interventional treatments provide good functional outcomes for patients with lower-grade brain AVMs

Interventional treatments provide good functional outcomes for patients with lower-grade brain AVMs

Interventional treatments--especially surgery--provide good functional outcomes and a high cure rate for patients with lower-grade arteriovenous malformations (AVMs) of the brain, reports the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. [More]
Advertisement
Advertisement